NEO neogenomics.com: Rasio rega marang prakiraan pendapatan
NeoGenomics, Inc. (NEO) is implementing AI and DNA sequencing for precision cancer treatment, although the PAMA law is reducing the profitability of its B2B platform. The forward P/S metric helps assess this balance, with the current metric standing at 2.70. The price action smooths out the contradictions between technological leadership and regulatory pressure, while a strategic alliance with pharma behemoths accelerates the market launch of targeted therapies.
Rincian analitis perusahaan NeoGenomics, Inc.
- rega saiki lan proyeksi nilai saham:
- data kapitalisasi saham perusahaan:
- indikator nilai buku ekuitas:
- indikator total utang lan likuiditas perusahaan:
Total Utang marang Modal NeoGenomics, Inc.|NEO - Rasio tanggungan utang jangka dawa marang modal|Utang jangka cendhak marang modal NeoGenomics, Inc.|NEO - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku NeoGenomics Corp|NEO - Gunggunge utang jangka dawa|Kewajiban jangka cendhak perusahaan NeoGenomics|Rasio cepet neogenomics.com
- data bathi bisnis lan rasio investasi:
NEO - Asil keuangan resik|Bathi sing dikarepake NeoGenomics, Inc.|NEO - Pangali rega marang bathi|Pangali Forward P/E NeoGenomics Laboratories|NEO - Pangali rega marang bathi tumrap wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan NeoGenomics Corp|NEO - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan NeoGenomics|NEO - Bathi saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan neogenomics.com|NEO - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep NeoGenomics, Inc.
- rincian pendapatan lan dodolan:
Analisis kabeh metrik perusahaan:NEO (NeoGenomics)
When assessing the asset quality of NeoGenomics, Inc. (NEO), it is essential to compare current market value with revenue generation potential. The forward P/S multiple reflects the ratio of market capitalization to projected revenue, allowing for an assessment of whether the price is overextended relative to future sales. For NeoGenomics, Inc. (NEO), the high predictability of oncology testing orders mitigates the volatility risks associated with this metric. Stable cash flows provide greater protection for investment capital during extreme metric fluctuations.
Analisis perusahaan pesaing
Multiplikator Forward P/S LIN (Linde)|Air Products & Chemicals, Inc. (APD) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|DD - Rasio rega marang prakiraan pendapatan|IP (IP Corp) - Kapitalisasi marang prakiraan pendapatan|ppg.com (PPG) - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep dow.com (DOW)|Rasio rega marang prakiraan pendapatan LyondellBasell|Multiplikator forward rega marang pendapatan IFF Inc. (IFF)|Multiplikator Forward P/S RPM|Rasio kapitalisasi marang dodolan sing dikarepake Entegris Corporation|Multiplikator Forward P/S SUZ (Suzano S.A.)|WLK - Multiplikator forward rega marang pendapatan|ALB - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake Israel Chemicals ICL|NEU (Afton Chemical) - Multiplikator forward rega marang pendapatan|Eastman Kodak Chemical - Rega forward marang dodolan|AXTA (Axalta Coating Systems) - Multiplikator Forward P/S|elementsolutionsinc.com (ESI) - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan Sociedad Química y Minera de Chile (SQM)|Celanese Corp - Kapitalisasi marang prakiraan pendapatan|Multiplikator Forward P/S SXT (Sensient Corp)|CBT - Multiplikator forward rega marang pendapatan|HWKN: Multiplikator forward rega marang pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake avient.com AVNT|H.B. Fuller (FUL) - Rasio rega marang prakiraan pendapatan|Kapitalisasi marang prakiraan pendapatan MEOH|WDFC (WD-40 Corp) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Chemours Co. CC|Rasio rega marang prakiraan pendapatan Quaker Chemical (KWR)|PCT - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Multiplikator Forward P/S ASH (Ashland)|NGVT - Multiplikator forward rega marang pendapatan|Innospec Corp - Multiplikator Forward P/S|Rega forward marang dodolan MTX (Minerals Technologies Corp)|DQ: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep sylvamo.com (SLVM)|Rasio rega marang prakiraan pendapatan Huntsman|Multiplikator forward rega marang pendapatan Albany International Corp (AIN)|Multiplikator Forward P/S CLMT|Rasio kapitalisasi marang dodolan sing dikarepake Rogers Materials|Rasio rega marang prakiraan pendapatan Stepan Company SCL|Rasio kapitalisasi marang dodolan sing dikarepake ecovyst.com (ECVT)|REX: Multiplikator forward rega marang pendapatan|ASP Isotopes Inc - Rasio rega marang pendapatan sing dikarepake|Tronox Limited (TROX) - Rasio rega marang prakiraan pendapatan|Ferroglobe Group - Rega forward marang dodolan|Multiplikator forward rega marang pendapatan WLKP|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep compassminerals.com CMP|Rasio rega marang prakiraan pendapatan Kronos Worldwide (KRO)|Mativ Holdings Inc - Kapitalisasi marang prakiraan pendapatan|Multiplikator Forward P/S LXU (LSB Corp)|Braskem Corp (BAK) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|KOP - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep advansix.com|OEC: Multiplikator Forward P/S|Prakiraan rega marang pendapatan Rayonier Advanced Materials Inc. RYAM|ADUR (Aduro Corp) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Magnera Group MAGN|Rasio rega marang prakiraan pendapatan Clearwater Paper (CLW)|tredegar.com - Kapitalisasi marang prakiraan pendapatan|Rasio rega marang prakiraan pendapatan Core Molding Technologies, Inc. CMT|FutureFuel Corp (FF) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|FSI - Rasio rega marang prakiraan pendapatan|Alto Ingredients, Inc. (ALTO) - Multiplikator forward rega marang pendapatan|FEAM: Multiplikator Forward P/S|TSE - Rasio kapitalisasi marang dodolan sing dikarepake|ORGN (Origin Materials Inc) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Northern Technologies International Corporation (NTIC)|Rasio rega marang prakiraan pendapatan LanzaTech Global Inc (LNZA)|Rasio kapitalisasi marang dodolan sing dikarepake ymaunivers.com|New Era Helium - Multiplikator forward rega marang pendapatan|Rega forward marang dodolan BSLK|BioNexus Gene Lab Corporation - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake Gulf Resources Inc. GURE|cneny.com (CNEY) - Rasio rega marang prakiraan pendapatan|Kapitalisasi marang prakiraan pendapatan ALTM|DNMR (Danimer Scientific) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Glatfelter Corp. (GLT)|Multiplikator forward rega marang pendapatan GRFX (Graphex Group Limited)|Rasio kapitalisasi marang dodolan sing dikarepake U.S. Silica Holdings, Inc.|Rasio rega marang prakiraan pendapatan Invizyne IZTC
